Sequent Scientific zooms as its arm gets EIR for analytical laboratory at Bengaluru

20 Aug 2019 Evaluate

Sequent Scientific is currently trading at Rs. 71.15, up by 1.50 points or 2.15% from its previous closing of Rs. 69.65 on the BSE.

The scrip opened at Rs. 70.00 and has touched a high and low of Rs. 72.15 and Rs. 69.05 respectively. So far 33055 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 89.00 on 22-Jan-2019 and a 52 week low of Rs. 42.45 on 11-Oct-2018.

Last one week high and low of the scrip stood at Rs. 72.15 and Rs. 67.50 respectively. The current market cap of the company is Rs. 1755.25 crore.

The promoters holding in the company stood at 56.50%, while Institutions and Non-Institutions held 12.32% and 31.18% respectively.

Sequent Scientific’s wholly owned subsidiary -- Sequent Research (SRL) has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its GLP compliant, Analytical services laboratory at Bengaluru.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Viyash Scientific Share Price

201.50 7.40 (3.81%)
22-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×